Results 91 to 100 of about 3,728 (186)

BET bromodomain inhibition promotes neurogenesis while inhibiting gliogenesis in neural progenitor cells

open access: yesStem Cell Research, 2016
Neural stem cells and progenitor cells (NPCs) are increasingly appreciated to hold great promise for regenerative medicine to treat CNS injuries and neurodegenerative diseases.
Jingjun Li   +14 more
doaj   +1 more source

Differentially expressed genes in endothelial differentiation

open access: yes, 2005
By screening differentially expressed genes in mouse embryonic stem (ES) cells by subtractive hybridization, we identified three conserved but uncharacterized genes encoding bromodomain containing 3 (BRD3), protein lysine methyltransferase (PLM), and ...
Hideshi Ishii   +3 more
core   +1 more source

Binding of BET bromodomain mutants to acetylated histone peptides and inhibitors.

open access: yes, 2016
(A) BLI study showing the interaction of some mutants with acetylated histone peptides. Shown is the maximum response at a protein concentration of 20 μM after subtraction of non-acetylated reference peptides using a colour code as indicated in the ...
Cynthia Tallant (372948)   +7 more
core   +1 more source

Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign

open access: yesMolecules
A 3D structure-based pharmacophore model built for bromodomain-containing protein 4 (BRD4) is reported here, specifically developed for investigating and identifying the key structural features of the (+)-JQ1 known inhibitor within the BRD4 binding site.
Ester Colarusso   +7 more
doaj   +1 more source

brd3a is an important regulator of thrombopoiesis.

open access: yes, 2014
(A) Live confocal imaging of zebrafish embryos injected with hBRD3-GFP mRNA revealed the nuclear localization of hBRD3 and that it binds to mitotic chromosomes (white arrows).
Lauren Ferreira (595949)   +6 more
core   +1 more source

Supplementary Figure 3 from Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma

open access: yes, 2013
PDF file - 4 MB, (A) Reduced expression of BRD2, BRD3, BRD4 following expression of corresponding shRNA sequences was determined by qRT-PCR in T4302 CD133+ cells.
Reid C. Thompson (14985159)   +9 more
core   +1 more source

Figure S6 from BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast Cancer

open access: yes, 2019
Figure S6. BRD3 and BRD4 are associated with disease-specific survival in METABRIC cohort.
Suet-Feung Chin (13233)   +21 more
core   +1 more source

Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1

open access: yesScientific Reports, 2017
The bromodomain protein Brd4 is an epigenetic reader and plays a critical role in the development and maintenance of leukemia. Brd4 binds to acetylated histone tails and activates transcription by recruiting the positive elongation factor P-TEFb.
Tim-Michael Decker   +6 more
doaj   +1 more source

Effect of siRNAs directed toward different BET proteins on ApoA-I mRNA levels in Huh7 cells.

open access: yes, 2013
A. Individual BRD2 and pooled BRD3 siRNAs. siRNAs were transfected for 48% DMSO. Protein knockdown was 56%, 42% and 44% for Brd2#1, #2 and #3 siRNAs and 86% for pooled Brd3 siRNAs. B. Individual BRD4 siRNAs.
Robert K. Suto (504423)   +14 more
core   +1 more source

Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review

open access: yesCase Reports in Pathology, 2015
Background. Nuclear protein in testis (NUT) midline carcinoma (NMC) is a very rare and aggressive malignancy. In more than two-thirds of these NMC cases, a fusion between NUT and BRD4 or BRD3 has been documented; other variants are rare.
Shiho Kuroda   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy